The Ready-to-Eat Meals for Cardiovascular Health Study (REACH)

June 1, 2026 updated by: Pablo Monsivais, Washington State University

The Ready-to-EAt Meals for Cardiovascular Health (REACH) Study

The proposed project explores the acceptability and health benefits of ready-to-eat (RTE) meals based on the Dietary Approaches to Stop Hypertension (DASH) eating plan. The researchers have developed 14 recipes following the DASH eating plan, which is recommended for the prevention of cardiovascular disease (CVD). The prepackaged meals will be processed using Washington State University (WSU) microwave technologies to ensure food safety. In this pilot study, a sample of 30 participants will be recruited by to study the impact of the DASH meals on blood pressure. All meals will be provided to participants, who will consume the meals daily over a period of 4 weeks. Daily and weekly monitoring of participants (blood pressure and weight) will allow us to gain a scientific understanding on the preventive power of healthy diets in lowering blood pressure and reducing CVD risk.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Spokane, Washington, United States, 99202
        • Washington State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or female
  • 18 years old or older
  • BMI 18.5-40.0 kg/m2
  • Daily access to working internet, microwave, refrigerator, and freezer
  • English fluency

Exclusion Criteria:

  • Regular use of drugs that affect BP, including weight loss medications
  • Diagnosed hypertension OR systolic BP >130 and/or diastolic BP >80
  • Diagnosis of any hypotensive disorders OR systolic BP <100 and/or diastolic BP<65
  • Dietary restrictions, including allergy/intolerances
  • Presence or history of diabetes
  • Previous cardiac event, congestive heart failure, or angina
  • Weight loss or gain>15lb in previous 3 months
  • Following a diet to increase or decrease body weight
  • Cancer diagnosis or treatment in past 2 years
  • ≥14 alcoholic drinks/week for men; ≥ 7 alcoholic drinks/week for women
  • Use of nicotine, marijuana, or illicit drugs
  • Pregnancy, planned pregnancy, or breastfeeding
  • Inability to comprehend the nature of the study or instructions
  • No access to the internet
  • Planning to leave the Spokane area during the study
  • Not fluent in the English language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Ready-to-eat meals
Pre-Post
Participant group to consume ready-to-eat meals in accordance with the DASH diet for a period of 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: through study completion, measured weekly for 5 weeks
To determine dietary patterns on blood pressure using an omron blood pressure monitor.
through study completion, measured weekly for 5 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight (kg)
Time Frame: through study completion, measured weekly for 5 weeks
To determine dietary patterns on body weight (kg) using a Angel USA 400 Pound Physician Digital Scale.
through study completion, measured weekly for 5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pablo Monsivais, PhD, MPH, Washington State University
  • Principal Investigator: Martine M Perrigue, PhD, RDN, Washington State University
  • Principal Investigator: Catherine Jarrett, PhD, RDN, Washington State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2022

Primary Completion (Actual)

May 1, 2023

Study Completion (Actual)

May 1, 2023

Study Registration Dates

First Submitted

July 15, 2022

First Submitted That Met QC Criteria

July 20, 2022

First Posted (Actual)

July 25, 2022

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Ready-to-eat meals

Subscribe